CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 25 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,125 | -25.1% | 250,000 | 0.0% | 0.00% | – |
| Q2 2023 | $384,500 | -37.4% | 250,000 | -50.0% | 0.00% | – |
| Q1 2023 | $614,250 | +116.9% | 500,000 | +100.0% | 0.00% | – |
| Q4 2022 | $283,250 | +3.4% | 250,000 | 0.0% | 0.00% | – |
| Q3 2022 | $274,000 | -93.8% | 250,000 | -93.2% | 0.00% | – |
| Q2 2022 | $4,415,000 | -24.5% | 3,655,000 | +7.3% | 0.00% | – |
| Q1 2022 | $5,851,000 | +3.4% | 3,405,000 | 0.0% | 0.00% | – |
| Q4 2021 | $5,661,000 | +7.6% | 3,405,000 | 0.0% | 0.00% | – |
| Q3 2021 | $5,263,000 | -4.1% | 3,405,000 | 0.0% | 0.00% | – |
| Q2 2021 | $5,486,000 | +3.1% | 3,405,000 | 0.0% | 0.00% | – |
| Q1 2021 | $5,322,000 | +11.8% | 3,405,000 | 0.0% | 0.00% | – |
| Q4 2020 | $4,760,000 | +24.9% | 3,405,000 | 0.0% | 0.00% | – |
| Q3 2020 | $3,812,000 | +7.0% | 3,405,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,564,000 | -39.9% | 3,405,000 | -46.8% | 0.00% | -100.0% |
| Q1 2020 | $5,929,000 | – | 6,405,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $4,888,000 | 0.98% |
| III Capital Management | 3,669,000 | $4,453,000 | 0.41% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,972,000 | $4,789,000 | 0.29% |
| MACKAY SHIELDS LLC | 6,783,000 | $8,195,000 | 0.20% |
| Warberg Asset Management LLC | 722,000 | $875,000 | 0.19% |
| ZAZOVE ASSOCIATES LLC | 1,628,000 | $1,967,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,564,000 | $4,312,000 | 0.12% |
| Teton Advisors, Inc. | 350,000 | $423,000 | 0.09% |
| Calamos Wealth Management LLC | 823,000 | $998,000 | 0.09% |
| WESTWOOD HOLDINGS GROUP INC | 4,310,000 | $5,263,000 | 0.06% |